Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 26 min ago
Peer-reviewedCC BY-NC-NDMaternal-fetal medicine (Wolters Kluwer Health, Inc.)

Global, Regional, and National Burden of Neural Tube Defects and Digestive Congenital Anomalies in Newborns, 1990–2021, With Projections to 2050: Results From the 2021 Global Burden of Disease Study

Abstract

Objective:. To provide global, regional, and national estimates of disability-adjusted life years (DALYs) for neural tube defects (NTDs) and digestive congenital anomalies (DCAs) from 1990 to 2021, with projections to 2050, to inform resource allocation and identify high-burden populations. Methods:. Using data from the Global Burden of Disease 2021 study, we analyzed the burden of NTDs and DCAs through descriptive and trend analyses. Age-standardized rates were examined by sex, age, region, and socio-demographic index (SDI). Temporal trends from 1990 to 2021 were assessed using estimated annual percentage change (EAPC). Future trends were forecast using exponential smoothing and ARIMA models. Results:. Between 1990 and 2021, the global burden of NTDs and DCAs declined. The age-standardized incidence rate (ASIR) of NTDs decreased from 2.94 to 1.95, while the ASIR of DCAs fell from 8.09 to 7.42. DALYs for both conditions also declined. Females consistently had higher ASIRs and age-standardized DALY rates than males, with the largest burden in children under 5 years. Low SDI regions experienced the highest burden, while high-middle SDI regions saw the fastest decline. Projections indicate a continued decrease in the burden of NTDs and DCAs through 2050. Conclusion:. Although the global burden of NTDs and DCAs has decreased over the past three decades, substantial disparities persist, particularly among women and populations in low-SDI regions. These findings highlight the need for targeted public health initiatives, optimized allocation of healthcare resources, and strengthened monitoring and intervention measures to reduce disparities in the disease burden of birth defects.

Related

  1. Global, regional, and national burden of chronic hepatitis C including cirrhosis from 1990 to 2021, alongside projections for the next 15 years.
    Shicheng Gu, Yaojian Shao, Chenyu Jiang +2
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Global, Regional, and National Burden of Ovarian Cancer Among Women of Reproductive Age, 1990–2021, with Projections to 2040: A Global Burden of Disease Study 2021 Analysis
    Xiao-Long Yang, Su-Su Yang, Jia-Ming Hou +6
    International Journal of Women's HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  3. Global, regional, and national levels and trends in under 5, infant, and neonatal mortality during 1990-2024 with scenario based projections to 2030: modelling study
    David Sharrow, Lucia Hug, Yang Liu +2
    BMJPeer-reviewedCC BY10 citedObstetrics, gynaecology & paediatricsOpenAlex
  4. Managing Choledocholithiasis in Rare Congenital Hepatobiliary Anomalies: A Report of Three Cases
    Andreja Ocepek, Luka Strniša, Sabina Vadnjal Đonlagić +2
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Missed, Misclassified or Misunderstood? Clinician Perspectives on Congenital Uterine Anomalies in Australia and New Zealand
    Kyra Innis, Boon Lim, Julie Quinlivan +1
    The Australian & New Zealand journal of obstetrics & gynaecologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
BibTeX
@article{zeng2026global,
  title = {{Global, Regional, and National Burden of Neural Tube Defects and Digestive Congenital Anomalies in Newborns, 1990–2021, With Projections to 2050: Results From the 2021 Global Burden of Disease Study}},
  author = {Hong Zeng and Hao Chen and Qiao He and Danqing Zhao and Yang Pan},
  journal = {Maternal-fetal medicine (Wolters Kluwer Health, Inc.)},
  year = {2026},
  month = sep,
  doi = {10.1097/fm9.0000000000000377},
  url = {https://europepmc.org/article/PMC/PMC13706510},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Global, Regional, and National Burden of Neural Tube Defects and Digestive Congenital Anomalies in Newborns, 1990–2021, With Projections to 2050: Results From the 2021 Global Burden of Disease Study
AU  - Hong Zeng
AU  - Hao Chen
AU  - Qiao He
AU  - Danqing Zhao
AU  - Yang Pan
PY  - 2026
DA  - 2026/09/03
JO  - Maternal-fetal medicine (Wolters Kluwer Health, Inc.)
DO  - 10.1097/fm9.0000000000000377
UR  - https://europepmc.org/article/PMC/PMC13706510
AB  - Objective:. To provide global, regional, and national estimates of disability-adjusted life years (DALYs) for neural tube defects (NTDs) and digestive congenital anomalies (DCAs) from 1990 to 2021, with projections to 2050, to inform resource allocation and identify high-burden populations. Methods:. Using data from the Global Burden of Disease 2021 study, we analyzed the burden of NTDs and DCAs through descriptive and trend analyses. Age-standardized rates were examined by sex, age, region, and socio-demographic index (SDI). Temporal trends from 1990 to 2021 were assessed using estimated annual percentage change (EAPC). Future trends were forecast using exponential smoothing and ARIMA models. Results:. Between 1990 and 2021, the global burden of NTDs and DCAs declined. The age-standardized incidence rate (ASIR) of NTDs decreased from 2.94 to 1.95, while the ASIR of DCAs fell from 8.09 to 7.42. DALYs for both conditions also declined. Females consistently had higher ASIRs and age-standardized DALY rates than males, with the largest burden in children under 5 years. Low SDI regions experienced the highest burden, while high-middle SDI regions saw the fastest decline. Projections indicate a continued decrease in the burden of NTDs and DCAs through 2050. Conclusion:. Although the global burden of NTDs and DCAs has decreased over the past three decades, substantial disparities persist, particularly among women and populations in low-SDI regions. These findings highlight the need for targeted public health initiatives, optimized allocation of healthcare resources, and strengthened monitoring and intervention measures to reduce disparities in the disease burden of birth defects.
SN  - 2096-6954
SN  - 2641-5895
ER  -